Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Up – What’s Next?

Bavarian Nordic (OTCMKTS:BVNRY)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $9.69, but opened at $10.19. Bavarian Nordic shares last traded at $10.07, with a volume of 10,418 shares traded.

Bavarian Nordic Price Performance

The business has a 50 day simple moving average of $9.87 and a 200 day simple moving average of $10.01. The company has a market capitalization of $2.38 billion, a price-to-earnings ratio of 13.17 and a beta of 1.21.

Bavarian Nordic (OTCMKTS:BVNRY) last released its quarterly earnings results on Wednesday, May 13th. The company reported $0.01 EPS for the quarter. Bavarian Nordic had a return on equity of 9.37% and a net margin of 19.74%.The company had revenue of $165.70 million for the quarter.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.